SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

VKTX RSS Feed
Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: greens12, BrazenBull
Search This Board: 
Last Post: 12/16/2017 10:48:43 AM - Followers: 39 - Board type: Free - Posts Today: 0

 
Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2
    2
    2
     
 

VK0612

Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.
 

Overview

Pills

We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

SureTrader
Interactive Brokers Advertisement
VKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Current Report Filing (8-k) 12/11/2017 04:26:56 PM
VKTX News: Viking Therapeutics Announces Closing of Public Offering of Common Stock 12/11/2017 04:15:00 PM
VKTX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 12/07/2017 04:40:46 PM
VKTX News: Current Report Filing (8-k) 12/07/2017 06:04:54 AM
VKTX News: Viking Therapeutics Announces Pricing of $12.8 Million Public Offering of Common Stock 12/06/2017 08:08:00 PM
PostSubject
#1146   Building strong support at this level, almost ready greens12 12/16/17 10:48:43 AM
#1145   Very happy to be trading around these levels BrazenBull 12/16/17 02:36:08 AM
#1144   I haven’t had a chance to look into Titan V 12/14/17 11:08:57 AM
#1143   Very interesting thoughts, nice to be mentioned and BrazenBull 12/13/17 10:27:51 PM
#1142   I see VKTX repeating MRNS story. They did Titan V 12/13/17 01:21:05 PM
#1141   Viking Therapeutics: Expecting Further Upside In 2018 greens12 12/12/17 10:26:58 AM
#1140   VKTX forming a Bullish Flag chart, next greens12 12/12/17 10:13:15 AM
#1139   Waffles, you truly are an incredible man sir. BrazenBull 12/12/17 12:13:55 AM
#1138   Any thoughts on the closing of the offering? BrazenBull 12/12/17 12:12:10 AM
#1137   MDGL PT raised to $170 from $82 at Titan V 12/11/17 09:19:25 AM
#1136   Hey Bull, great questions. I didn’t proofread ZeWaffleBaron 12/11/17 12:03:53 AM
#1135   yes , the valuation needs to be at greens12 12/10/17 10:49:19 AM
#1134   Waffles gets a Top Hat at 5.00. greens12 12/10/17 10:45:28 AM
#1133   I think it would put share price closer On Rocket 12/10/17 09:35:40 AM
#1132   Hello to my fellow brothers. Waffles, I would BrazenBull 12/10/17 12:39:27 AM
#1131   You are correct. (eom) Titan V 12/09/17 04:45:47 PM
#1130   Agreed Rolling. ZeWaffleBaron 12/09/17 04:20:21 PM
#1129   https://t.co/etkwtQwfhl $105 profit in $VKTX I bought this makemoney18 12/08/17 11:37:35 PM
#1128   thank you Titan :) i'm now following you kei 12/08/17 10:26:08 PM
#1127   Late q2 with luck. For end of q1 Rolling inflaton 12/08/17 09:36:54 PM
#1126   I think the company has said 1H’18. I’m Titan V 12/08/17 07:47:34 PM
#1125   hi Titan kei 12/08/17 06:03:55 PM
#1124   Need to catch up to MDGL valuation....that would greens12 12/08/17 12:28:44 PM
#1123   News imminent Mr. Greenjeans!! Congrats to you On Rocket 12/08/17 12:04:09 PM
#1122   Busting out over 4.00 :] ...happy Friday to all.... greens12 12/08/17 11:56:30 AM
#1121   $VKTX @ ph2 dose Titan V 12/07/17 11:40:21 PM
#1120   Now that the MC is over $100M, VKTX Titan V 12/07/17 11:15:24 PM
#1119   Hey Waffles, really hope you are doing well BrazenBull 12/07/17 11:04:27 PM
#1118   The MDGL to VKTX valuation difference has to Rolling inflaton 12/07/17 06:39:53 PM
#1117   Waffles, appreciate your insight as always. Flubadub 12/07/17 05:56:18 PM
#1116   * * $VKTX Video Chart 12-07-17 * * ClayTrader 12/07/17 04:29:54 PM
#1115   As MDGL news disseminates in the nash community, ZeWaffleBaron 12/07/17 03:51:29 PM
#1114   biotech jim from Biotech Values board: The VKTX Titan V 12/07/17 01:26:06 PM
#1113   Let’s do it! Titan V 12/07/17 12:16:44 PM
#1112   alright :] lets ride....see ya at greens12 12/07/17 12:10:38 PM
#1111   Got back in today! (eom) Titan V 12/07/17 11:07:57 AM
#1110   Shorts are getting crushed today :] Go VKTX greens12 12/07/17 10:44:52 AM
#1109   Market wanted to give them a higher valuation Titan V 12/06/17 11:05:26 PM
#1108   Morons zoomlik 12/06/17 09:54:30 PM
#1107   VKTX prices 5.90M* shares @ $2.50 Titan V 12/06/17 09:19:39 PM
#1106   Clay you remind me of Sheldon off Big Lynx7 12/06/17 06:20:22 PM
#1105   * * $VKTX Video Chart 12-06-17 * * ClayTrader 12/06/17 05:07:18 PM
#1104   Sorry .. wrong board zoomlik 12/06/17 04:10:01 PM
#1103   Buyback announcement .. small but I still like zoomlik 12/06/17 04:08:53 PM
#1102   Shitty management got lucky or else they would zoomlik 12/06/17 09:48:19 AM
#1101   MDGL out with their NASH readout. Home Flubadub 12/06/17 09:24:59 AM
#1100   News here?!? Lone Wolf 12/06/17 09:20:21 AM
#1099   Management gets an F .. we should be zoomlik 12/06/17 08:39:32 AM
#1098   I am in the minority here, thinking Flubadub 12/06/17 02:26:43 AM
#1097   Good that means I can increase my position Lynx7 12/05/17 09:26:06 PM
PostSubject